𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of HSV-1 protease by benzoxazinones

✍ Scribed by Richard L. Jarvest; Martin J. Parratt; Christine M. Debouck; Joselina G. Gorniak; L. John Jennings; Halina T. Serafinowska; James E. Strickler

Book ID
103983581
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
215 KB
Volume
6
Category
Article
ISSN
0960-894X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Inhibition of HIV protease by monoclonal
Inhibition of HIV protease by monoclonal antibodies
✍ P. Rezacova; J. Brynda; M. Fabry; M. Horejsi; R. Stouracova; J. Lescar; V. Chita πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 272 KB

## Abstract The protease of HIV plays a critical role in the maturation of the infectious particles of the virus. The enzyme has therefore been extensively studied with the objective of developing therapeutics that inhibit viral proliferation. We have produced monoclonal antibodies specific for the

HIV-1 protease inhibition potential of f
HIV-1 protease inhibition potential of functionalized polyoxometalates
✍ Andreas FlΓΌtsch; Thilo Schroeder; Markus G. GrΓΌtter; Greta R. Patzke πŸ“‚ Article πŸ“… 2011 πŸ› Elsevier Science 🌐 English βš– 577 KB

Polyoxometalates (POMs) are interesting biomedical agents due to their versatile anticancer and antiviral properties, such as remarkable anti-HIV activity. Although POMs are tunable and easily accessible inorganic drug prototypes in principle, their full potential can only be tapped by enhancing the